Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/02/19 → 11/02/24 |
Phase II Trial PD-L1/PD-1 Blockade Avelumab (MSB0010718C) With Chemoradiotherapy for Locally Advanced Resectablet3b-4/N1-2 Rectal Cancer (Averec Trial)
- Segelov, Eva (Primary Chief Investigator (PCI))
Project: Other